Literature DB >> 2452832

Phenotypic and functional characterization of human cytolytic T cells lacking expression of CD5.

B E Bierer1, Y Nishimura, S J Burakoff, B R Smith.   

Abstract

Although the CD5 (T1) antigen was initially described as a pan-T cell membrane glycoprotein, we report that 14 of 40 normal individuals were found to have 5% or greater of their blood mononuclear cells characterized as CD3 (T3)+ but CD5- by dual immunofluorescence flow cytometry. These cells expressed normal quantities of surface CD3 and CD2 but low levels of CD7, were CD8+ and CD4-, and CD16-. In order to determine whether cells of this phenotype were functional, six CD5- cytolytic T lymphocyte (CTL) clones isolated from normal individuals were studied. The CD5- CTL clones all demonstrated normal cytolytic activity against appropriate target cells. Monoclonal antibodies (MAbs) directed against CD3, CD8, CD2, and lymphocyte function-associated antigen 3, but not against CD5, inhibited cytolytic activity. Changes in intracellular calcium [( Ca2+]i) in response to anti-CD5 and anti-CD3 MAbs were measured. Stimulation by anti-CD5 MAb alone did not give rise to a change in [Ca2+]i. However, under conditions of limiting concentrations of anti-CD3 MAb, preincubation of normal CD5+, but not CD5-, clones with anti-CD5 MAb led to a dramatic enhancement in the ability of anti-CD3 MAb to elicit a rise in [Ca2+]i. We conclude that CD5- T lymphocytes represent a normal lymphoid phenotype. Although CD5 may be involved in T cell activation when present, these CD5- CTL clones appear to express normal cytolytic activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452832      PMCID: PMC442569          DOI: 10.1172/JCI113468

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation.

Authors:  A M Krensky; E Robbins; T A Springer; S J Burakoff
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

2.  Biologic functions of the OKT1 T cell surface antigen. I. The T1 molecule is involved in helper function.

Authors:  Y Thomas; E Glickman; J DeMartino; J Wang; G Goldstein; L Chess
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

3.  The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions.

Authors:  A M Krensky; F Sanchez-Madrid; E Robbins; J A Nagy; T A Springer; S J Burakoff
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

4.  Molecular interactions in human T cell-mediated cytotoxicity to EBV II. Monoclonal antibody OKT3 inhibits a post-killer-target recognition/adhesion step.

Authors:  C D Tsoukas; D A Carson; S Fong; J H Vaughan
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

5.  Cellular immunoabsorption using monoclonal antibodies. Selective removal of T cells from peripheral blood and bone marrow.

Authors:  R J Berenson; L J Levitt; R Levy; R A Miller
Journal:  Transplantation       Date:  1984-08       Impact factor: 4.939

6.  Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.

Authors:  R O Dillman; D L Shawler; J B Dillman; I Royston
Journal:  J Clin Oncol       Date:  1984-08       Impact factor: 44.544

7.  Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.

Authors:  F Sanchez-Madrid; A M Krensky; C F Ware; E Robbins; J L Strominger; S J Burakoff; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  A new human T-cell differentiation antigen: unexpected expression on chronic lymphocytic leukemia cells.

Authors:  P J Martin; J A Hansen; R C Nowinski; M A Brown
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

9.  Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia.

Authors:  K A Foon; R W Schroff; P A Bunn; D Mayer; P G Abrams; M Fer; J Ochs; G C Bottino; S A Sherwin; D J Carlo
Journal:  Blood       Date:  1984-11       Impact factor: 22.113

10.  Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies.

Authors:  U Landegren; U Ramstedt; I Axberg; M Ullberg; M Jondal; H Wigzell
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  3 in total

1.  Stimulation of CD5 enhances signal transduction by the T cell antigen receptor.

Authors:  J B Imboden; C H June; M A McCutcheon; J A Ledbetter
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

2.  Characterization of normal human CD3+ CD5- and gamma delta T cell receptor positive T lymphocytes.

Authors:  E F Spour; T Leemhuis; L Jenski; R Redmond; D Fillak; J Jansen
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

3.  T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity.

Authors:  Adrienne Verhoef; Clare Alexander; A Barry Kay; Mark Larché
Journal:  PLoS Med       Date:  2005-03-29       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.